Raday Gilead bought RDHL
October 1, 2026 · Form 4 insider transaction
Raday Gilead bought 27,560,000 shares of RedHill Biopharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,560,000
Price
$0.00
Total value
N/A
InsiderRaday Gilead
Role—
SecurityAmerican Depository Shares
Transaction codeM: Option exercise
Transaction dateOctober 1, 2026
Filing dateOctober 6, 2026
Shares owned after131,690,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.